contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


biostock-pila-pharma-stands-out-in-next-generation-obesity-pipeline

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

PILA PHARMA är ett kliniskt bioteknikbolag baserat i Malmö, Sverige. Bolaget utvecklar nya orala läkemedel för globalt vanliga metabola sjukdomar som diabetes, fetma och hjärt-kärlsjukdomar samt terapier för smärtbehandling. Bolaget har erhållit en särläkemedelsbeteckning i USA för den smärtsamma sällsynta sjukdomen Erythromelalgia. Bolaget är specialiserat på utveckling av farmaceutiska läkemedel baserade på TRPV1-antagonister.

PILA PHARMA

Obesity has grown into one of the world’s largest health crises, and the rise of long-acting GLP-1 drugs has turned the field into one of pharma’s most lucrative. Yet despite the hype, the treatment...

<div class="mfn-preamble"><p><strong>Obesity has grown into one of the world’s largest health crises, and the rise of long-acting GLP-1 drugs has turned the field into one of pharma’s most lucrative. Yet despite the hype, the treatment landscape remains largely uniform. Now, momentum is shifting toward oral, next-generation therapies targeting new mechanisms — aiming for greater scalability, tolerability, and patient adherence. Among the emerging contenders, Pila Pharma’s TRPV1 inhibitor XEN-D0501 stands out as a compelling alternative.</strong></p></div><div class="mfn-body"><p>Read the full article at&nbsp;<a rel="noopener" href="https://www.biostock.se/en/">biostock.se</a>:<br><a rel="noopener" href="https://biostock.se/en/2025/11/pila-pharma-sticker-ut-bland-nasta-generations-fetmabehandlingar/">https://biostock.se/en/2025/11/pila-pharma-sticker-ut-bland-nasta-generations-fetmabehandlingar/</a><br>This is a press release from<strong>&nbsp;BioStock - Connecting Innovation &amp; Capital</strong>.&nbsp;<a rel="noopener" href="https://www.biostock.se/">https://www.biostock.se</a></p></div><div class="mfn-footer mfn-about mfn-e63cb96431c5"><p><strong class="mfn-heading-1">Follow BioStock</strong><br>Stay up to date with the latest news, upcoming events, recent videos, and podcasts! Subscribe to our newsletters at <a rel="noopener" href="https://www.biostock.se/newsletter">https://www.biostock.se/newsletter</a>&nbsp;<br>Follow BioStock on social media: <a rel="noopener" href="https://www.linkedin.com/company/biostock/">LinkedIn</a> and <a rel="noopener" href="https://www.facebook.com/biostock.se%22%20/t%20%22_blank">Facebook</a>! &nbsp;<br>&nbsp;<br><strong>About BioStock</strong>&nbsp;<br>BioStock is the leading digital hub for the Nordic life science sector. Focusing on biotechnology, medical technology, diagnostics, and drug development, we provide daily news updates, in-depth analyses, exclusive interviews, and innovation-promoting networking events – all to keep you informed about industry developments.&nbsp;&nbsp;<br>BioStock – Connecting Innovation &amp; Capital.&nbsp;</p></div>